<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Psychiatry">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>7</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Arsenicosis: Is it a Protective or Predisposing Factor for Mental Illness?</title>
    <FirstPage>180</FirstPage>
    <LastPage>3</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Devosri</FirstName>
        <LastName>Sen</LastName>
        <affiliation locale="en_US">Department of Clinical Psychology, Central Institute of Psychiatry (C.I.P.), Kanke, Ranchi, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Partha</FirstName>
        <LastName>Sarathi Biswas</LastName>
        <affiliation locale="en_US">MD, DPM 505 HariRam Appartment, Chandi chowk, Gandhinagar Ranchi- 834008, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Chronic arsenic poisoning (Arsenicosis) is a global health&#xA0;risk, and it has been reported to improve the fitness, especially in&#xA0;altitudinal sickness in therapeutic dose. Scarcity of systematic study on&#xA0;psychiatric co-morbidities in Arsenicosis motivated us to conduct this&#xA0;research. The aim of this study was to estimate the co-morbid&#xA0;psychiatric disorders in patients with arsenicosis and to examine&#xA0;whether natural arsenic exposure and toxicity is protective or&#xA0;detrimental for mental health.
Method: Out of 1477 arsenicosis patients aged 18 to 65 years, 1169&#xA0;were finally assessed after excluding those who were disinclined to&#xA0;participate or those who had any organ failure or prior psychiatric&#xA0;disorder in themselves or their first-degree relatives. We applied&#xA0;General Health Questionnaire-12 (GHQ-12) and Brief Psychiatric Rating&#xA0;Scale (BPRS) to screen psychiatric symptoms. Finally, 191 patients with&#xA0;BPRS score &gt; 30 were structurally interviewed using the Schedules for&#xA0;Clinical Assessment in Neuropsychiatry (SCAN).
Results: Of the 1169 participants in our study, 18.99 % of the&#xA0;arsenicosis patients had psychiatric ailments. Common psychiatric&#xA0;manifestations were depression (8.47%), mixed anxiety and depressive&#xA0;disorder (4.61%), adjustment disorder in the form of mixed anxiety and&#xA0;depressive reaction, and brief depressive reaction (2.22%), and suicidal&#xA0;attempts (1.53%).&#xA0;
Conclusion: Considering the higher prevalence of psychiatric ailments&#xA0;in arsenicosis compared to general population of the same territory, it is&#xA0;necessary to screen psychological disorders in them. Conducting&#xA0;studies with control groups to further evaluate the impact of arsenicosis&#xA0;on mental health is warranted.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/175</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/175/171</pdf_url>
  </Article>
</Articles>
